- Home
- CCCC vs AUDC Comparison
CCCC vs AUDC Comparison
Compare CCCC & AUDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- AUDC
- Stock Information
- Founded
- CCCC 2015
- AUDC 1992
- Country
- CCCC United States
- AUDC Israel
- Employees
- CCCC N/A
- AUDC N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- AUDC Telecommunications Equipment
- Sector
- CCCC Health Care
- AUDC Utilities
- Exchange
- CCCC Nasdaq
- AUDC Nasdaq
- Market Cap
- CCCC 104.4M
- AUDC 282.4M
- IPO Year
- CCCC 2020
- AUDC 1999
- Fundamental
- Price
- CCCC $2.26
- AUDC $9.30
- Analyst Decision
- CCCC Buy
- AUDC Buy
- Analyst Count
- CCCC 3
- AUDC 3
- Target Price
- CCCC $12.00
- AUDC $11.67
- AVG Volume (30 Days)
- CCCC 1.6M
- AUDC 49.7K
- Earning Date
- CCCC 07-31-2025
- AUDC 07-29-2025
- Dividend Yield
- CCCC N/A
- AUDC 3.73%
- EPS Growth
- CCCC N/A
- AUDC 57.57
- EPS
- CCCC N/A
- AUDC 0.56
- Revenue
- CCCC $39,783,000.00
- AUDC $242,474,000.00
- Revenue This Year
- CCCC N/A
- AUDC $1.54
- Revenue Next Year
- CCCC N/A
- AUDC $1.41
- P/E Ratio
- CCCC N/A
- AUDC $16.57
- Revenue Growth
- CCCC 98.56
- AUDC N/A
- 52 Week Low
- CCCC $1.09
- AUDC $7.70
- 52 Week High
- CCCC $7.66
- AUDC $12.72
- Technical
- Relative Strength Index (RSI)
- CCCC 63.62
- AUDC 55.77
- Support Level
- CCCC $1.36
- AUDC $9.57
- Resistance Level
- CCCC $2.17
- AUDC $9.85
- Average True Range (ATR)
- CCCC 0.15
- AUDC 0.17
- MACD
- CCCC 0.05
- AUDC 0.00
- Stochastic Oscillator
- CCCC 67.11
- AUDC 78.87
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
About AUDC AudioCodes Ltd.
AudioCodes Ltd develops and sells onverged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.